Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease

Annals of Internal Medicine

Volumn 161, Issue 1, 2014, Pages 82-83

  Lambers Heerspink, Hiddo J ^a   Gaillard, Carlo J A M ^a   Gansevoort, Ron T ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BENAZEPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; RAMIPRIL;

CHRONIC KIDNEY DISEASE; END STAGE RENAL DISEASE; HUMAN; HYPERTENSION; LETTER; MACROALBUMINURIA; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR;

HUMANS; MASS SCREENING; RENAL INSUFFICIENCY, CHRONIC;

EID: 84903593786     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/L14-5013-3     Document Type: Letter

References (7)

1. Qaseem A, Hopkins RH Jr, Sweet DE, Starkey M, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. Screening, monitoring, and treatment of stage 1 to 3 chronic kidney disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2013;159:835-47. [PMID: 24145991]
2. Gansevoort RT, de Zeeuw D, de Jong PE. Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Kidney Int. 1994; 45:861-7. [PMID: 8196289] (Pubitemid 24094500)
3. Heerspink HJ. Therapeutic approaches in lowering albuminuria: travels along the renin-angiotensin-aldosterone-system pathway. Adv Chronic Kidney Dis. 2011;18: 290-9. [PMID: 21782135]
4. Hou FF, Xie D, Zhang X, Chen PY, Zhang WR, Liang M, et al. Renoprotection of Optimal Antiproteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency. J Am Soc Nephrol. 2007;18: 1889-98. [PMID: 17494885] (Pubitemid 46870325)
5. Witte EC, Lambers Heerspink HJ, de Zeeuw D, Bakker SJ, de Jong PE, Gansevoort R. First morning voids are more reliable than spot urine samples to assess microalbuminuria. J Am Soc Nephrol. 2009;20:436-43. [PMID: 19092125]
6. Incidence, prevalence, patient characteristics and treatment modalities. In: U.S. Renal Data System. 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2013: 215-28. Accessed at www.usrds.org/2013/pdf/v2-ch1-13.pdf on 25 November 2013.
7. Rensma PL, Hagen EC, Wetzelfs JFM, Kaasjager HAH, Ter Wee PM, Smulders YM. [Dutch Guideline Chronic Renal Failure.] Utrecht, the Netherlands: Kwaliteits-koepel; 2009. Accessed at www.kwaliteitskoepel.nl/assets/structured- files/NIV/Betrokkenbij/Chronische-nierschade-2009.pdf on 25 November 2013.